Emergent BioSolutions Initiates Phase 1 Study Evaluating
GAITHERSBURG, Md., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has dosed the first participant in...
Source: globenewswire.com
📰 Profectus Lassa News
Profectus Lassa News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Profectus Lassa. Real-time updates on events, politics, business and more.